Tiger Aesthetics Medical, LLC acquired Certain Assets from Sientra, Inc. (OTCPK:SIEN.Q).
April 23, 2024
Share
Tiger Aesthetics Medical, LLC agreed to acquire Certain Assets from Sientra, Inc. (OTCPK:SIEN.Q) for $42.5 million on April 2, 2024. Tiger Aesthetics will also assume assume certain liabilities of the Company, including up to $7 million in cure costs for certain assumed contracts, all the Company?s warranties for breast implants sold prior to the closing date, and all of the Company?s customer contracts. In a related transaction, Nuance Intermediary, LLC entered into a definitive agreement to acquire substantially all the assets of Sientra, Inc. for $8 million on April 2, 2024. Both transactions are subject to the approval of the United States Bankruptcy Court for the District of Delaware at a hearing currently scheduled for April 10, 2024, and other customary closing conditions. As on April 4, 2024 Sientra, Inc. (OTCPK:SIEN.Q) entered into Asset purchase agreement with Tiger Aesthetics Medical, LLC to sale asset of the company. All breast implant warranties under Sientra?s current warranty programs will be honored through closing. Sientra is represented by Kirkland & Ellis LLP and Pachulski Stang Ziehl & Jones as legal counsel, Stifel / Miller Buckfire as investment banker, and Berkeley Research Group, LLC as financial advisor. Tiger Aesthetics Medical, LLC is represented by Blank Rome LLP as legal counsel and H.C. Wainwright & Co. as investment banker.
Tiger Aesthetics Medical, LLC completed the acquisition of Certain Assets from Sientra, Inc. (OTCPK:SIEN.Q) on April 24, 2024.
Project Sage Oldco Inc., formerly Sientra, Inc., is a medical aesthetics company. The Company is engaged in transformative treatments and technologies focused on advancing plastic surgery. The Company provides medical aesthetics products to certified plastic surgeons and patients. It has developed a portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants, breast tissue expanders, and fat transfer system for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The Company's brands also include Sientra, Sientra Platinum20, Sientra Full Circle, Sientra Smooth, Sientra Teardrop, AlloX, AlloX2, Anatomical Controlled, BIOCORNEUM, Curve, Dermaspan, Luxe, Softspan, Silishield, AuraClens and Viality.